Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SO | DUK |
|---|---|---|
| Price | $83.29 | $113.89 |
| Change today | ▼ 0.22% | ▼ 0.25% |
| Market cap | $95.81B | $88.80B |
| Return, 3 months | -12.3% | -9.2% |
| Return, year to date | -2.1% | -0.3% |
| Return, 1 year | -8.9% | -4.7% |
| P/E (TTM) | 20.1 | 17.1 |
| P/B | 2.4 | 1.7 |
| P/E percentile vs own 5y | 22nd | 0th |
| Dividend yield | 3.58% | 3.74% |
| Revenue growth (YoY, latest qtr) | +0.1% | +1.1% |
| Net profit growth (YoY) | +39.3% | +13.7% |
| Gross margin | 48.3% | 51.3% |
| Operating margin | 24.2% | 26.6% |
| Net margin | 15.4% | 15.6% |
| Return on equity | 12.7% | 10.0% |
| Analyst target vs. price | +17.9% | +20.3% |
| Analyst buy share | 25% | 57% |
| RSI (14) | 25 | 28 |
| 30-day volatility | 12.9% | 12.5% |
| Max drawdown, 1 year | -15.0% | -12.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.